SMS Pharmaceuticals Limited — Board Meeting, 31-07-2026: Outcome of Board Meeting

SMS Pharma Board approved Q1 consolidated net profit of ₹20.20 Cr. Mr. Ramesh Babu Potluri re-appointed as Chairman & MD for 5 years. A ₹50 Cr loan to subsidiary SMS Peptides also approved. All subject to shareholder nod. Sep 16 is the record date for any FY25-26 dividend.